Summary
Serum lipoproteins and apolipoproteins were studied at diagnosis and 6,12 and 24 months later in 30 consecutive children aged 3–15 years with newly detected Type 1 (insulin-dependent) diabetes mellitus (December 1982–October 1984) and in 44 healthy control children. Serum triglycerides at diagnosis were significantly higher than after 6–24 months and also higher than in the control group (p<0.001). At follow-up, triglycerides in the very low density lipoproteins and low density lipoproteins were restored to normal, while high density lipoprotein triglycerides remained high. Serum cholesterol at onset of diabetes was significantly higher than in the control children (p<0.01), mainly because of increased very low density lipoprotein cholesterol (p<0.001). Cholesterol in serum and in the serum lipoprotein fractions was similar to that in the control children at follow-up, except that high density lipoprotein cholesterol was higher in the diabetic children after 6 months. The concentrations of the serum apolipoproteins A-I, A-II and B were higher at onset of diabetes than in the control children (p<0.001, p<0.01, p<0.05 respectively), with a significantly increased ratio of apolipoprotein A-I to A-II in the diabetic children (p<0.001). The serum apolipoprotein concentrations were normalised during treatment. The ratio of apolipoprotein A-I to B did not differ from that in control children. On admission, there were strong positive correlations between HbA1c and the concentrations of the very low density lipoproteins and the low density and high density lipoprotein triglycerides. There were also significantly positive correlations (p<0.01) between HbA1c and apolipoprotein A-I and apolipoprotein B respectively. After treatment these correlations disappeared, except for a positive correlation with very low density lipoprotein triglycerides at 2 years. In conclusion, at diagnosis, when the diabetic children were in an insulin-deficient state, all apolipoproteins and serum lipoprotein fractions, except cholesterol in high density lipoproteins and low density lipoproteins were increased. During the first two years of treatment the concentrations of lipoproteins and apolipoproteins in serum are similar to those in healthy children.
Article PDF
Similar content being viewed by others
References
Pyörälä K, Laakso M (1983) Macrovascular disease in diabetes mellitus. In: Mann JI, Pyörälä K, Teusscher A (eds) Diabetes in epidemiological perspective. Churchill Livingstone, Edinburgh London Melbourne New York, pp 183–247
Ewald U, Gustafson S, Tuvemo T, Vessby B (1984) Increased high density lipoproteins in diabetic children. Eur J Pediatr 142: 154–156
Klujber L, Molnar D, Kardos M, Jaszai V, Soltecz G, Mestyan J (1979) Metabolic control, glycosylated haemoglobin and high density lipoprotein cholesterol in diabetic children. Eur J Pediatr 132: 284–297
Lopes-Virella MF, Wohltmann JH, Loadholt CB, Buse MG (1981) Plasma lipids and lipoproteins in young insulin-dependent diabetic patients: relationship with control. Diabetologia 21: 216–223
Ewald U, Tuvemo T, Vessby B, Wålinder O (1982) Serum apolipoproteins A-I, A-II and B in diabetic children and matched healthy controls. Acta Paediatr Scand 71: 15–18
Ewald U, Gustafsson I-B, Tuvemo T, Vessby B (1982) Fatty acid composition of serum lipids in diabetic children and their matched healthy controls. Ups J Med Sci 87: 111–117
Havel RJ, Eder HA, Bragdon JH (1955) The determination and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34: 1345–1353
Seigler L, Wu WT (1981) Separation of serum high-density lipoprotein for cholesterol determination: ultracentrifugation vs precipitation with sodium phosphotungstate and magnesium chloride. Clin Chem 27: 838–841
DaCol P, Kostner GM (1983) Immuniquantification of total apolipoprotein B in serum by nephelometry: influence of lipase treatment and detergents. Clin Chem 29: 1045–1050
Barter PJ, Ha YG, Calvert GB (1981) Studies of esterified cholesterol in subfractions of plasma high-density lipoproteins. Atherosclerosis 38: 165–175
Nikkilä EA, Kekki M (1973) Plasma triglyceride transport kinetics in diabetes mellitus. Metabolism 22: 1–22
Taskinen MR, Nikkilä EA (1979) Lipoprotein lipid activity of adipose tissue and skeletal muscle in insulin-deficient human diabetics. Diabetologia 17: 351–356
Pfeifer MA, Brunzell JD, Best JD, Judzewitsch RG, Halter JB, Porte D Jr (1983) The response of plasma triglyceride, cholesterol and lipoprotein lipase to treatment in non-insulin-dependent diabetic subjects without familial hypertriglyceridemia. Diabetes 32: 525–531
Chait A, Robertson TH, Brunzell JD (1981) Chylomicronemia syndrome in diabetes mellitus. Diabetes Care 4: 343–348
Nikkilä EA, Hormila P (1978) Serum lipids and lipoprotein in insulin treated diabetes. Demonstration of increased high-density lipoprotein concentrations. Diabetes 27: 1078–1086
Nikkilä EA (1981) High density lipoproteins in diabetes. Diabetes 30 [Suppl 2]: 82–87
Dunn FL, Pietri A, Raskin P (1981) Plasma lipid and lipoprotein levels with continuous subcutaneous insulin infusion in type I diabetes mellitus. Ann Intern Med 95: 426–431
Falko JM, O'Dorisio TM, Lataland S (1982) Improvement of high-density lipoprotein-cholesterol levels. J Am Med Assoc 247: 37–39
Lawson P, Trayner I, Rosenstock J, Kohner E (1984) The effect of continuous subcutaneous insulin infusion on serum lipids. Diabete Metabol (Paris) 10: 239–244
Harno K, Nikkilä EA, Kuusi T (1980) Plasma HDL-cholesterol and post-heparin plasma hepatic endothelial lipase (HL) activity: relationship to obesity and non-insulin dependent diabetes (NIDDM). Diabetologia 19: 281
Abrams JJ, Ginsberg H, Grundy SM (1982) Metabolism of cholesterol and plasma triglycerides in non-ketotic diabetes mellitus. Diabetes 31: 903–910
Kennedy L, Baynes JW (1984) Non-enzymatic glycosylation and the chronic complications of diabetes: an overview. Diabetologia 26: 93–98
Eckel RH, Albers JJ, Cheung MC, Wahl PW, Lindgren FT, Bierman EL (1981) High density lipoprotein composition in insulin-dependent diabetes mellitus. Diabetes 30: 132–138
Schafer EJ, Zech LA, Jenkins LL, Bronzert TJ, Rubalcaba EA, Lindgren FT, Aamodt RL, Brewer HB (1982) Human apolipoprotein A-I and A-II metabolism. J Lipid Res 23: 850–862
Nicoll A, Miller NE, Lewis B (1980) High density lipoprotein metabolism. Adv Lipid Res 17: 53–106
Tall AR, Small DM (1978) Plasma high density lipoproteins. N Engl J Med 299: 1232–1236
Green PHR, Glickman RM, Saudek CD, Blum CB, Tall AR (1979). Human intestinal lipoproteins. Studies in chyluric subjects. J Clin Invest 64: 233–242
O'Looney P, Irwin D, Briscoe P, Vahouny GV (1985) Lipoprotein composition as a component in the lipoprotein clearance defect in experimental diabetes. J Biol Chem 260: 428–432
Gonen B, White N, Schonfeld G, Skor D, Miller P, Santiago J (1985) Plasma levels of apoprotein B in patients with diabetes mellitus: the effect of glycaemic control. Metabolism 34: 675–679
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kobbah, M., Vessby, B. & Tuvemo, T. Serum lipids and apolipoproteins in children with Type 1 (insulin-dependent) diabetes during the first two years of the disease. Diabetologia 31, 195–200 (1988). https://doi.org/10.1007/BF00290584
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00290584